[1] Zhang H, Zhou XD, Shapiro MD, Lip GYH, Tilg H, Valenti L, et al. Global burden of metabolic diseases, 1990 − 2021. Metabolism 2024;160:155999. https://doi.org/10.1016/j.metabol.2024.155999.
[2] Stefan N, Schulze MB. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol 2023;11(6):426 − 40. https://doi.org/10.1016/S2213-8587(23)00086-4.
[3] Lotta LA, Abbasi A, Sharp SJ, Sahlqvist AS, Waterworth D, Brosnan JM, et al. Definitions of metabolic health and risk of future type 2 diabetes in BMI categories: a systematic review and network meta-analysis. Diabetes Care 2015;38(11):2177 − 87. https://doi.org/10.2337/dc15-1218.
[4] Ambroselli D, Masciulli F, Romano E, Catanzaro G, Besharat ZM, Massari MC, et al. New advances in metabolic syndrome, from prevention to treatment: the role of diet and food. Nutrients 2023;15(3):640. https://doi.org/10.3390/nu15030640.
[5] Williams PL, Webb C. The Delphi technique: a methodological discussion. J Adv Nurs 1994;19(1):180 − 6. https://doi.org/10.1111/j.1365-2648.1994.tb01066.x.
[6] Zhang M, Wang LH, Wu J, Huang ZJ, Zhao ZP, Zhang X, et al. Data resource profile: China Chronic Disease and Risk Factor Surveillance (CCDRFS). Int J Epidemiol 2022;51(2):e1 − 8. https://doi.org/10.1093/ije/dyab255.
[7] Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 2020;73(1):202 − 9. https://doi.org/10.1016/j.jhep.2020.03.039.
[8] Eckel N, Li YP, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol 2018;6(9):714 − 24. https://doi.org/10.1016/S2213-8587(18)30137-2.
[9] Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990 − 2019: update from the GBD 2019 study. J Am Coll Cardiol 2020;76(25):2982 − 3021. https://doi.org/10.1016/j.jacc.2020.11.010.
[10] Xing QQ, Li JM, Chen ZJ, Lin XY, You YY, Hong MZ, et al. Global burden of common cancers attributable to metabolic risks from 1990 to 2019. Med 2023;4(3):168 − 81.e3. https://doi.org/10.1016/j.medj.2023.02.002.
[11] Qiu HL, Fan SJ, Zhou KX, He ZN, Browning MHEM, Knibbs LD, et al. Global burden and drivers of hyperglycemia: estimates and predictions from 1990 to 2050. Innovation 2023;4(4):100450. https://doi.org/10.1016/j.xinn.2023.100450.
[12] Huang ZH, Sun AJ. Metabolism, inflammation, and cardiovascular diseases from basic research to clinical practice. Cardiol Plus 2023;8(1):4 − 5. https://doi.org/10.1097/CP9.0000000000000037.
[13] Castro A, Signini ÉF, De Oliveira JM, Di Medeiros Leal MCB, Rehder-Santos P, Millan-Mattos JC, et al. The aging process: a metabolomics perspective. Molecules 2022;27(24):8656. https://doi.org/10.3390/molecules27248656.
[14] Costanzo M, Caterino M, Sotgiu G, Ruoppolo M, Franconi F, Campesi I. Sex differences in the human metabolome. Biol Sex Differ 2022;13(1):30. https://doi.org/10.1186/s13293-022-00440-4.
[15] Gao W, Sanna M, Chen YH, Tsai MK, Wen CP. Occupational sitting time, leisure physical activity, and all-cause and cardiovascular disease mortality. JAMA Netw Open 2024;7(1):e2350680. https://doi.org/10.1001/jamanetworkopen.2023.50680.
[16] Khalaf F, Barayan D, Saldanha S, Jeschke MG. Metabolaging: a new geroscience perspective linking aging pathologies and metabolic dysfunction. Metabolism 2025;166:156158. https://doi.org/10.1016/j.metabol.2025.156158.